N. Anthony Coles, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 11,200 shares at $584.57 ($6.5M) on 2022-09-06, disclosed to the SEC on 2022-09-08.
Open-market sale of $6.5M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $576.73 | 300 | $173K | 2.7% |
| 2 | $577.07 | 500 | $289K | 4.4% |
| 3 | $578.25 | 273 | $158K | 2.4% |
| 4 | $578.25 | 273 | $158K | 2.4% |
| 5 | $579.85 | 550 | $319K | 4.9% |
| 6 | $579.85 | 550 |
| $319K |
| 4.9% |
| 7 | $580.44 | 688 | $399K | 6.1% |
| 8 | $580.44 | 688 | $399K | 6.1% |
| 9 | $581.44 | 822 | $478K | 7.3% |
| 10 | $581.44 | 822 | $478K | 7.3% |
| 11 | $582.56 | 1,220 | $711K | 10.9% |
| 12 | $582.56 | 1,220 | $711K | 10.9% |
| 13 | $583.16 | 1,045 | $609K | 9.4% |
| 14 | $583.16 | 1,045 | $609K | 9.4% |
| 15 | $584.57 | 602 | $352K | 5.4% |
| 16 | $584.57 | 602 | $352K | 5.4% |
| Total | $581.59 avg | 11,200 | $6.5M | 100% |
| Filing → |
| CERE | SELL | 2024-05-14 | $2.1M | — | Filing → |
| CERE | SELL | 2024-04-03 | $2.1M | — | Filing → |
| CERE | SELL | 2024-03-06 | $2.1M | — | Filing → |